Gram-negative prosthetic joint infection treated with debridement, prosthesis retention and antibiotic regimens including a fluoroquinolone

Hsieh, 2009, Gram‐negative prosthetic joint infections: risk factors and outcome of treatment, Clin Infect Dis, 49, 1036, 10.1086/605593 Martinez‐Pastor, 2009, Outcome of acute prosthetic joint infections due to gram‐negative bacilli treated with open debridement and retention of the prosthesis, Antimicrob Agents Chemother, 53, 4772, 10.1128/AAC.00188-09 Brandt, 1997, Staphylococcus aureus prosthetic joint infection treated with debridement and prosthesis retention, Clin Infect Dis, 24, 914, 10.1093/clinids/24.5.914 Brouqui, 1995, Treatment of Pseudomonas aeruginosa‐infected orthopedic prostheses with ceftazidime‐ciprofloxacin antibiotic combination, Antimicrob Agents Chemother, 39, 2423, 10.1128/AAC.39.11.2423 Zimmerli, 2004, Prosthetic‐joint infections, N Engl J Med, 351, 1645, 10.1056/NEJMra040181 Di Bonaventura, 2004, Biofilm formation by Stenotrophomonas maltophilia: modulation by quinolones, trimethoprim‐sulfamethoxazole, and ceftazidime, Antimicrob Agents Chemother, 48, 151, 10.1128/AAC.48.1.151-160.2004 Widmer, 1991, Killing of nongrowing and adherent Escherichia coli determines drug efficacy in device‐related infections, Antimicrob Agents Chemother, 35, 741, 10.1128/AAC.35.4.741 Yassien, 1995, Modulation of biofilms of Pseudomonas aeruginosa by quinolones, Antimicrob Agents Chemother, 39, 2262, 10.1128/AAC.39.10.2262 Abdi‐Ali, 2006, Bactericidal activity of various antibiotics against biofilm‐producing Pseudomonas aeruginosa, Int J Antimicrob Agents, 27, 196, 10.1016/j.ijantimicag.2005.10.007 Keays, 2009, A retrospective analysis of biofilm antibiotic susceptibility testing: a better predictor of clinical response in cystic fibrosis exacerbations, J Cyst Fibros, 8, 122, 10.1016/j.jcf.2008.10.005 Greenberg, 1987, Treatment of bone, joint, and soft‐tissue infections with oral ciprofloxacin, Antimicrob Agents Chemother, 31, 151, 10.1128/AAC.31.2.151 Zervos, 2003, Relationship between fluoroquinolone use and changes in susceptibility to fluoroquinolones of selected pathogens in 10 United States teaching hospitals, 1991–2000, Clin Infect Dis, 37, 1643, 10.1086/379709 Marculescu, 2008, Polymicrobial prosthetic joint infections: risk factors and outcome, Clin Orthop Relat Res, 466, 1397, 10.1007/s11999-008-0230-7 Zimmerli, 1998, Role of rifampin for treatment of orthopedic implant‐related staphylococcal infections: a randomized controlled trial. Foreign‐Body Infection (FBI) Study Group, JAMA, 279, 1537, 10.1001/jama.279.19.1537 Marculescu, 2006, Outcome of prosthetic joint infections treated with debridement and retention of components, Clin Infect Dis, 42, 471, 10.1086/499234